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It  has  been  shown  in  several  systems  that  the  manifestation  of antigen-specific 
immune suppression  involves the interactions  of suppressor T  cell subsets  (1-8).  In 
some  instances,  these  interactions  depend  on  the  recognition  of unique  idiotypic 
determinants  present  on  lymphoid  cells  (6,  9-12),  or regulatory  molecules derived 
from these cells  (13-15).  Thus,  these T  cell interactions  appear to require idiotypic 
recognition  in a  fashion analogous to the antibody network originally proposed by 
Jerne (16). 
Previously, we have described a  suppressor cell system in which suppressor T  cells 
specifically affect idiotype-bearing B lymphocytes both in vivo and in vitro (17).  In 
contrast to several systems in which idiotype-specific suppression has been induced by 
the  injection  of anti-idiotypic  antiserum  (10,  15,  18)  or idiotype itself (11,  19,  20), 
suppression  in  this  system  was  induced  directly  with  antigen.  Spleen  cells  were 
covalently coupled with the 4-hydroxy-3-nitrophenyl acetyl (NP) 1 hapten and injected 
intravenously into syngeneic recipients. Spleen cells from these recipients specifically 
suppress NP  b idiotype-bearing B cell clones. That is, spleen cells from donors treated 
with NP-coupled cells were capable of suppressing the NP  b idiotypic response of NP- 
primed B cells when added at the initiation of in vitro culture. The idiotype specificity 
of these suppressor cells suggested that they interacted with target cells by recognition 
of idiotypic determinants.  Based on these observations, it was hypothesized that the 
suppressor cell described in vitro may correspond to the effector-phase suppressor cell 
(Ts  ~)  involved in the suppression of NP delayed-type hypersensitivity responses  (6). 
To  test  this  hypothesis  and  to characterize  this  cell population  further,  suppressor 
ceils were examined in vitro for their ability to act in the effector phase of an immune 
response, and for the genetic restrictions on their activity. The data presented herein 
indicate  that  NP-induced  immune suppression of a  B  cell response is mediated,  at 
least in part, by an idiotype-binding Lyt-l-, Lyt-2  ÷ T  cell that can function during 
the  effector  phase  of  an  immune  response.  The  results  are  consistent  with  the 
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contention that this cell population may be involved in the regulation of both T  and 
B cell immune responses. 
Materials and Methods 
Mice.  C57BL/6 male and (23H/HeJ male mice were purchased from The Jackson Labo- 
ratory, Bar Harbor, Maine. C3H.NB and (2KB male mice were bred in the Harvard Medical 
School facilities.  All expe:imental animals were between 8 and 12 wk of age at the beginning 
of immunization.  Animals were age-matched in each experiment. 
Antigens.  NP22-bovine  gammaglobulin (BGG),  NP6-poly-(e-GluSn-L-Lys35-L-Phe  a)  (GI.zh), 
NP-keyhole limpet hemocyanin (KLH), and NP-Ficoll were conjugated by the reaction of NP- 
O-suceinimide (Biosearch,  San Rafael, Calif.) with GLth (lot GLP1-71-199; Miles-Yeda Ltd., 
Rehovot,  Israel),  KLH,  BGG  (Sigma  (2hemical  Co.,  St.  Louis,  Mo.),  or  AECMTS-Ficoll 
(Biosearch)  as described previously (6). The NP-KLH and NP-Ficoll had an average of 30 and 
17 NP groups per 100,000 mol wt, respectively. 
Immunization.  Mice were immunized intraperitoneatly with  150 #g NP-KLH in a  0.2-ml 
mixture containing 25% pertussis vaccine (Michigan Dept. of Public Health, Lansing, Mich.). 
Haptenated Cell Preparation.  NP-coupled spleen cells were made as described previously (17). 
Cells  were  washed  extensively in  minimum essential  medium  (MEM)  before  intravenous 
injection of 3 X 107 NP-eoupled cells into syngeneic recipients. 
In  Vitro Subcultures.  Spleen cells  from control mice or mice treated  7 d  earlier with NP- 
coupled spleen cells were teased and washed under sterile conditions. These cells were added to 
Linbro culture wells (Flow Laboratories, Inc., Hamden, Conn.) at a concentration of 7.5 ×  106 
cells/ml/well in Mishell-Dutton culture medium containing 10% fetal calf serum, (FCS; lot 
95045,  Microbiological Associates,  Walkersville, Md.). (2ultures were incubated at 37°(2  in a 
10% (202 atmosphere in rocking culture boxes and fed daily with 0.1 ml supplementary medium 
for a  4-d subculture period. Cells were then pooled, washed, and 5  X  105 viable normal or 
suppressor cells were added to 7.5 ×  108 NP~primed cells. 
Purification of T Cells and Fractionation of NP  Idiotype-binding Cells.  The method of Mage et al. 
(21) was used to purify splenic T  cells from subculture. Purified rabbit anti-mouse immuno- 
globulin (RAMIg; 5 mi of a  1 mg/ml solution) was added to 100- ×  15-mm polystyrene petri 
plates (1005; Falcon Plastics, Div. of Becton, Dickinson & Co., Oxnard, Calif.) and incubated 
for  1 h at room temperature. Unbound antibody was washed off and 8 ×  107 viable cells from 
subcultures were added for a 1-h incubation  period at 20°(2. The nonadherent T cell population 
was recovered by gentle swirling. Less than 1.0% of these cells stained with a fluorescent RAMIg 
antiserum. Idiotype-specifie suppressor cells were separated according to the method of Abbas 
et al. (22). Anti-NP antiserum was prepared by immunization  of C57BL/6 (Igh-1 b) or C3H.NB 
(Igh-1 j) mice with 100 #g NP-BGG in pertussis vaccine and specific antibody was obtained by 
affinity  purification. 5 ml of a  1 mg/ml solution of purified anti-NP antibodies from C57BL/6 
(Igh-1 °) or (23H.NB (Igh-1 j) mice were incubated on 100- ×  15-mm polystyrene petri dishes for 
1 h at room temperature. After removal of immunoglobulin  solutions, the plates were washed 
as above.  10 ×  106-15 ×  106 purified suppressor T  cells were added to each plate in a  total 
volume of 5 ml MEM containing 5% F(2S. (2ells were incubated for  1 h at room temperature. 
Nonadherent cells were removed and the dishes  were washed extensively with warm (20°C) 
media. After addition of 5.0  ml cold media, the  dishes  were  incubated on ice  for  30  min. 
Adherent cells were resuspended with vigorous pipetting, washed, and counted.  1.0-5 ×  105 
viable fractionated cells were then added to responder cultures challenged 4 d earlier with 100 
ng NP-Ficoll or NP-GI~. 
Anti-Lyt  Treatment.  5 X  106 suppressor cells from subcultures were washed twice in MEM 
without FCS, pelleted, and incubated for 45 min at 20°(2 with 2-15 #1 monoclonal, arsinilate 
(ABA)-conjugated  anti-Lyt-1 or anti-Lyt-2 antibody (Becton, Dickinson & Co., Oxnard, (2alif.). 
Cells were washed twice and resuspended in 15 ffl rabbit anti-ABA antibody (Becton, Dickinson 
& Co.) and incubated for 45 min at 20°(2. Treated cells were then washed and incubated in 0.3 
ml  rabbit  complement  (C)  diluted  1:5  in  MEM  containing  1%  DNase.  After  a  30-min 
incubation at 37°C, the cells were washed in MEM and 1.8-3.5  X 105 viable cells were added 
to responder cultures challenged 4 d earlier with NP-Ficoll. Control cells were treated only with 
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In  Vitro Responder Cultures.  C57BL/6 mice were immunized intraperitoneally with  150 pg 
NP-KLH with 25% pertussis vaccine. 4 wk later, their spleens  were removed and teased into a 
single cell suspension under sterile conditions. Cells were washed and resuspended in Mishell- 
Dutton media containing 10% FCS. 7.5 ×  106 viable NP-primed cells was added to each well 
of Linbro culture plates. Cultures were challenged with  100 ng NP-GI~ or NP-Ficoll in 20 pl. 
A  primary sheep erythrocyte (SRBC)  response was obtained by addition of 2 ×  106 washed 
SRBC to culture wells containing 7.5 ×  106 normal, unprimed spleen cells. All cultures were 
incubated in rocking boxes at 37°C in a  10% CO2 atmosphere and were fed daily with 0.1 ml 
supplementary medium. 4 d after challenge, subcultured control or suppressor cells were added. 
5 d  after challenge, duplicate wells were pooled and assayed for total NP- or SRBC-specific 
plaque-forming cell  (PFC) responses in replicate slides. 
PFC Assay.  NP- or SRBC-specific  PFC  were  assayed as  reported  previously  (17).  NP  b- 
bearing B cells were inhibited from forming plaques by the addition of 3.0-4.0 ~1 anti-idiotypic 
reagent to each slide at the beginning of the assay. The control response was determined by 
addition of 3.0-4.0 #1 normal guinea pig gammaglobulin. The percent inhibition of PFC was 
calculated according to the formula: 
experimental PFC~ 
Percentage of inhibition =  1 -  control PFC  ,/  ×  100. 
Anti-NP  b Antiserum.  Anti-idiotypic antiserum specific for the NP  b idiotype was prepared as 
........  b-  -  e  described previously (23). This antiserum has been shown to specifically inhibit NP  ldlotyp - 
positive B cells in a plaque assay system (17). 
Results 
Idiotype-specific  Suppression  in the Effector  Phase.  In a  previous report  (17), we have 
shown that after a  4-d subculture,  spleen cells from mice treated  7 d  earlier with the 
intravenous injection of NP-coupled syngeneic spleen cells were capable of suppressing 
the expression  of NP  b idiotype-positive B  cells when  added to responder cultures  at 
the  time  of antigen  challenge.  Spleen  cells  from NP-spleen-cell-treated  donors  that 
were not subcultured  for a  4-d period failed to suppress  the in vitro response. These 
data  suggested  that  a  population  of effector-phase suppressor  cells  matured  during 
the subculture period. To determine whether suppressor cells were capable of affecting 
the  expression  of NP  b  idiotype-positive  B  cells  during  the  effector  phase  of the 
response,  mice were given  an  intravenous  injection  of 3  X  10 v syngeneic control or 
NP-modified  spleen  cells.  7  d  later,  spleen  cells  were  subcultured  for a  4-d  period, 
after which 5 ×  105 viable control or suppressor cells were added to NP-KLH primed 
responder cultures  that had been challenged in vitro 4  d  earlier with NP-FieolI. On 
the  following  day,  the  cultures  were  assayed  for  the  magnitude  and  the  idiotype 
content of the response. The percent idiotype-positive B cell clones was assayed by the 
ability of an NP  b idiotype-specific guinea pig antiserum  to inhibit  the formation of 
plaques.  The  data  in  Table  I  confirm  previous  experiments  demonstrating  the 
expression  of 75-100% idiotype-positive B  cells in cultures challenged with NP-GI_~ 
or NP-FicolI. The data also indicate that subcultured suppressor cells were capable of 
significantly  decreasing  the  magnitude  of immune  responsiveness  when  added  late 
after  antigenic  challenge  (Table  I).  Furthermore,  this  suppression  appeared  to  be 
idiotype specific because the response of cultures to which suppressor cells had been 
added was essentially nonidiotypic. Thus, subcultured cells derived  from NP-spleen- 
cell-treated  donors specifically suppressed  the  NP  b idiotypic response  in the effector 
phase of these in vitro responses. 
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TAaLE  I 
NP  b Idiotype-specific Suppression of Effector-Phase Responses In Vitro  * 
Antigen  Donor treatment  NP-specific PFC/culture X+  Percent inhibition  with anti-NP  b anti- 
log SE~  serum 4- SE§ 
NP-GL~  Control  11,000  75 
NP-spleen  3,400 (66)  0 
NP-Ficoll  Control  3,200 x+ 1.4  100 + 0 
NP-spleen  1,300 x+ 1.1 (59)  7 4- 7 
* C57BL/6 mice received an intravenous injection of 3 X  10  7 control or NP-coupled syngeneic spleen cells. 
7 d later, those spleen cells were cultured for a 4-d period. 5 ×  105 viable control or suppressor cells from 
these subcultures were then added to responder cultures challenged 4 d earlier with 100 ng NP-Ficoll or 
NP-GI~. 1 d later, duplicate wells were pooled and assayed for direct (NP-Ficoll) or indirect (NP-GL~) 
PFC responses. Data  from  one  experiment  with  NP-GL~  and  two experiments  with  NP-Ficoll  are 
presented. 
:~ The data are expressed as the geometric mean x+ log SE. The percent suppression relative to controls is 
presented in parentheses. 
§ The percent idiotype-positive response is expressed as the arithmetic mean 4- SE of the percent inhibition 
of plaque formation  in the presence of 3.0-4.0 ffl anti-NP  b antiserum  relative to the response in the 
presence of normal guinea pig IgG. 
tured cells from  NP-modified-cell-treated donors  resulted in the suppression of NP  b 
idiotype-positive B  cell clones, we next tested whether this suppressor cell population 
carried an anti-idiotypic receptor. Subcultured suppressor cells were T  cell-enriched 
by passage on RAMIg-coated petri dishes. These T  cells were subsequently passed on 
petri dishes coated with specifically purified anti-NP antibody either from C57BL/6 
mice (Igh-lb), which bear the NP  b idiotype, or from C3H.NB mice (Igh-lJ), which do 
not  bear  the  NP  b  idiotype.  Viable  cells  thus  fractionated  were  added  in  various 
concentrations to responder cultures challenged 4 d earlier with NP-Ficoll. The results 
from two representative experiments are presented in Table II. Purified suppressor T 
cells mediate this immune suppression because RAMIg nonadherent subcultured cells 
from NP-tolerized donors suppress the effector-phase immune response (Table II). In 
addition, these suppressor T  cells bound to NP  b idiotype-coated plates because as few 
as 1 ×  105-3 ×  105 idiotype adherent cells suppressed the NP response 46-100% in the 
effector phase, whereas the idiotype nonadherent fraction was completely depleted of 
suppressor activity. That the suppressor cells did not recognize NP hapten potentially 
bound by the purified antibody was demonsirated by the inability of cells adherent 
to plates coated with C3H.NB  anti-NP antibody to affect the response. As expected, 
all of the  suppressive  activity was  found  in  the  C3H.NB  anti-NP  antibody-coated 
plate  nonadherent  fraction.  Furthermore,  in  two  experiments  (data  not  shown) 
suppressor cells failed to bind to NP-bovine serum albumin-coated petri dishes. The 
results  indicate  that  subcultured  cells from  NP-modified  spleen-cell-treated donors 
were  T  cells  that  specifically recognized  NP  b  idiotypic determinants  and  did  not 
directly function by an antigen-bridging mechanism. 
Igh Homology Is Required to Transfer Suppression In Vitro.  Recent reports have indicated 
that  suppressor cells transferred  to normal  recipients must  be homologous with  the 
recipient at  the Igh locus  (24-26).  Because the NP  suppressor cells described above 
are idiotype specific, and because the gene that controls NP  b idiotype is linked to the 
Igh-1 b locus  (27,  28),  it would be expected that  these suppressor cells would  fail to DAVID  H.  SHERR  AND  MARTIN  E.  DORF  1449 
TABLE II 
Effector-Phase Suppressor  T  Cells Specifically  Adhere  to NP b Idiotype * 
Cells added to culture 
Fractionation of suppressor 
T cells 
NP-specific PFC* 
Experiment 1  Experiment 2 
5 ×  10  n control T  --  4,650  1,100 
5 x  l05 Ts  --  1,500 (68)  50 (95) 
5 x  105 Ts  NP  b nonadherent  5,350 (-15)  1,700 (-55) 
1-2 X  105 Ts  NP  b nonadherent  4,950 (-7)  1,250 (-14) 
1-3 ×  105 Ts  NP  b adherent  2,500  (46)  0 (100) 
5 ×  105 Ts  NP  i nonadherent  1,800 (61)  0 (100) 
1-2 X  105 Ts  NP  j nonadherent  1,350 (71)  550 (50) 
l0  b Ts  NP  i adherent  4,400 (5)  NT§ 
* C57BL/6 mice received an intravenous injection of 3 ×  107 control or NP-coupled syngeneic spleen cells. 
7 d later, these spleens were cultured for a 4-d subculture period. Control or suppressor cells from these 
subcultures were then T cell-enriched by passage over RAMIg-coated petri dishes before passage on NP  b- 
or  NPi-coated  dishes.  5  X  105  viable control or  fractionated T  suppressor cells  were  then added  to 
responder cultures challenged 4  d  earlier with  100 ng NP-Ficoll.  1 d  thereafter, duplicate wells  were 
pooled and assayed for direct NP-specific PFC responses. 
* The percent suppression relative to controls is presented in parentheses. 
§ Insufficient numbers of cells were recovered from Nlai-coated  plates to test this group. 
TABLE III 
Igh Restriction  of Effector-Phase  Suppressor Cells In  Vitro * 
Responder cell donors  Cells added to culture 
NP-specific PFC:I: 
Experiment 1  Experiment 2 
CKB (Igh-l~ 
C3H/HeJ (Igh-I  j) 
CKB control  5,150  2,830 
CKB suppressor  1,450 (72)  300 (89) 
C3H control  4,650  2,100 
C3H suppressor  4,680 (- 1)  2,900 (-38) 
CKB control  3,900  725 
CKB suppressor  4,250 (-9)  1,480 (-104) 
C3H control  3,580  1,430 
C3H suppressor  1,650 (54)  630 (56) 
* CKB or C3H/HeJ  mice received an intravenous injection of 3 ×  107 control or NP-coupled syngeneic 
spleen cells.  7 d later, their spleen cells were cultured for a 4-d subculture period. 5 X  105 viable control 
or suppressor cells were then added to CKB or C3H/HeJ responder cultures that had been challenged 4 
d earlier with 100 ng NP-Ficoll. 
* The percent suppression relative to controls is indicated in parentheses. 
suppress the response of a  non-Igh-1 b strain. To  test this prediction, spleen cells from 
Igh congenie CKB  or C3H/HeJ  mice that had been treated  7 d  earlier with syngeneic 
control  or  NP-modified  cells  were  subcultured  for  4  d.  5  ×  105  viable  control  or 
suppressor cells were then  added  to CKB  (Igh-1 b) or C3H  (Igh-I  j) responder  cultures 
that  had  been challenged  4  d  earlier with NP-Ficoll.  1 d  later, cultures were assayed 
for NP-specific PFC  responses. The  data  from two experiments  are presented in Table 
III.  Suppressor  cells  from  both  CKB  and  C3H  mice  were  effective  in  reducing  the 
response  of  syngeneic  responder  cells  in  the  effector  phase  by  54-89%.  However, 
neither  suppressor  population  was  capable  of diminishing  the  response  of Igh  mis- 
matched  responders.  Thus,  CKB  suppressor  cells  suppressed  CKB  but  not  C3H 1450  EFFECTOR-PHASE SUPPRESSION  OF PLAQUE-FORMING CELLS 
responder  cultures  and  vice  versa.  Effector-phase  suppressor,  therefore,  must  be 
homologous with the responder population at the Igh locus for expression of immune 
suppression. 
Presence of Lyt-2 Determinants on Effector-Phase  T Suppressor Cells.  To further charac- 
terize the effector-phase suppressor cell, its Lyt phenotype was determined. Suppressor 
cells obtained from subcultures were treated with monoclonal, ABA-conjugated anti- 
Lyt-1 or anti-Lyt-2 antibodies, followed by a  rabbit anti-ABA antiserum plus C.  1.8 
or 3.5 ×  105 viable control or treated suppressor cells were added to responder cultures 
challenged 4 d  earlier.  1 d  later, cultures were assayed for NP-specific PFC responses. 
The  results  from  a  representative experiment  are  presented  in  Table  IV.  Whereas 
treatment  with anti-Lyt-1 antibody did not  affect suppression, treatment  with anti- 
Lyt-2 completely ablated the ability of suppressor populations to reduce an immune 
response in the effector phase. Thus,  effeetor-phase T  suppressor cells obtained after 
subculture of cells from hapten-modified spleen-cell-treated donors bear Lyt-2 deter- 
minants. 
Specificity  of Effector-Phase  Suppressor  Cells.  It  has  previously  been  shown  that 
antigen-induced  suppressor cells may  act  nonspecifically in  the effector mode  once 
they have been stimulated specifically with antigen  (29,  30).  To determine whether 
suppressor cells obtained after subculture of cells from NP-spleen-cell-treated donors 
were capable of suppressing the response to an unrelated antigen in the effector phase, 
subcultured  suppressor cells were  added either  to  NP-KLH-primed  responder cells 
challenged 4  d  earlier with  NP-FicoI1, normal responder cells primed 4  d  earlier in 
vitro with  SRBC,  or  1:1  mixtures of NP-KLH-primed  and  normal cells challenged 
with  NP-Ficoll and  SRBC  together.  1  d  later,  cultures  were  assayed  for  NP-  and 
SRBC-specific PFC responses. The pooled and normalized data from five experiments 
are presented in Table V.  Effector-phase, subcultured suppressor cells did not affect 
the ability of cultures of normal cells to respond to SRBC.  In addition, in cultures in 
which both  the NP- and  SRBC-specific responses could be assayed simultaneously, 
subcultured cells that suppressed the NP-specific response 56%  in the effector phase 
failed  to  significantly  affect  the  SRBC-specific  response.  Thus,  in  these  in  vitro 
TABLE  IV 
Effector-Phase Suppressor Ceils Bear Lyt-2 Determinants* 
Cells added to culture  Antibody treatment  NP-speeific PFC~: 
3.5 ×  105 control  --  3,100 
3.5 ×  105 suppressor  --  1,400 (55) 
3.5 ×  105 suppressor  Anti-Lyt-1 + C  1,300 (58) 
3.5 ×  105 suppressor  Anti-Lyt-2 + C  3,500 (-12) 
1.8 ×  l0  s suppressor  --  1,200 (61) 
1.8 ×  105 suppressor  Anti-Lyt-1 + C  1,700 (55) 
1.8 ×  l0  s suppressor  Anti-Lyt-2 + C  3,900 (-26) 
* In this representative experiment, C57BL/6  mice received an intravenous injection of 3 ×  107 control or 
NP-coupled syngeneie spleen cells. 7 d later, their spleens were subcultured  for a 4-d period. Suppressor 
cells were then treated with ABA-conjugated anti-Lyt-1 or anti-Lyt-2 monoelonal antibody as indicated 
before treatment with rabbit anti-ABA plus C.  1.8 ×  105-3.5 ×  105 viable control or treated suppressor 
cells were added to responder cultures that had been challenged 4 d earlier with 100 ng NP-FicoI1. 1 d 
thereafter, duplicate wells were pooled and assayed for direct NP-specific PFC responses. 
:1: The percent suppression relative to controls is indicated in parentheses. DAVID H.  SHERR  AND MARTIN E.  DORF  1451 
TABLE  V 
Specificity of Effector-Phase Suppressor Cells In  Vitro * 
Antigen 
SRBC-specific 
NP-specific PFC/  PFCl/culture x  log 
culture x+ log SE$  SE 
Percent suppression + SE 
NP-specific§  SRBC-specific 
NP-Ficoll  1870 X 1.4  --  70 zt: 9  -- 
SRBC  --  1340 +4" 1.7  --  8 ±  7 
NP-Ficoll +  2390 X+ 1.2  1530 X 1.6  56 ±  13  15 ±  13 
SRBC 
* In this pool of five experiments, C57BL/6 mice were given an intravenous injection of 3 ×  107 control or 
NP-spleen cells. 7 d  later, their spleens were subcultured  for a 4-d period.  5 ×  105 viable control or 
suppressor cells were then added to NP-KLH-primed responder cells challenged 4 d earlier with NP- 
Ficoll, normal responder cells primed 4 d earlier in vitro with SRBC, or 1:1 mixtures of NP-KLH-primed 
and normal cells challenged with NP-Ficoll and SRBC together.  1 d later, cultures were assayed for NP- 
and SRBC-specific PFC responses. 
Geometric mean X+ log SE of PFC response per control culture. 
§ Arithmetic mean + SE. 
experiments, effector-phase suppressors did not appear to be capable of nonspecifically 
affecting the primary response to an unrelated particulate antigen even when specif- 
ically stimulated by an ongoing, NP-specific immune response. 
Discussion 
In  the  present  report,  the  ability of suppressor cells induced  by the  intravenous 
injection of NP-modified syngeneic spleen cells to  affect  the  in  vitro  Npb-idiotypic 
PFC  response  was  studied.  Previously,  it  had  been  shown  that  the  intravenous 
injection of NP-modified syngeneic cells induced at least two subsets of T  cells capable 
of suppressing  delayed-type  hypersensitivity  (DTH)  and  cutaneous  sensitivity  re- 
sponses in vivo (6,  23,  24,  26).  One  subset,  termed induction-phase suppressor cells, 
bound to NP and was capable of specifically reducing a  DTH  response when given at 
the time of antigen priming. The second subset, referred to as effector-phase suppressor 
cells, adhered to NP  b idiotype and was shown to be capable of suppressing the DTH 
response when given 5  d  after antigen priming, i.e., at the time of antigen challenge. 
Furthermore, it appeared that these subsets were causally related because injection of 
induction-phase suppressor cells with antigen induced effector-phase suppressor cells. 
An  extension  of  this  system  demonstrated  that  spleen  cells  from  mice  given  an 
intravenous  injection of NP-conjugated syngeneic spleen cells were  capable of sup- 
pressing  the  NP  b  idiotype fraction  of a  PFC  response  either  when  transferred  to 
normal syngeneic recipients or when subcultured for a  4-d period and then added to 
NP-KLH-primed  responder cultures  (17).  In those initial in vitro experiments, sub- 
cultured suppressor cells were  added to responder cultures at  the time of antigenic 
challenge.  Given  the  idiotype specificity of subcultured  suppressor  cells  from  NP- 
spleen-cell-treated donors,  it appeared that  these cells corresponded  to the effector- 
phase, idiotype-specific DTH  suppressor cells previously described (6). Based on this 
hypothesis, it was predicted that  this population of cells would suppress an ongoing 
immune  response  in  an  idiotype-specific fashion.  Therefore,  in  the  present  experi- 
ments,  suppressor cells were  added to  in  vitro cultures several days after antigenic 
challenge. The ability of these cells to suppress an ongoing immune response during 1452  EFFECTOR-PHASE  SUPPRESSION OF PLAQUE-FORMING CELLS 
the efferent phase defined them as effector-phase suppressor cells.  Because effector- 
phase suppressor cells were functional within a short period of time, it was likely that 
these  cells  represented  a  relatively  mature  population(s)  of lymphoid  cells.  The 
maturational  events  required  for  differentiation to  effector-phase suppressor  cells 
appeared  to take place  during the 4-d subculture  because spleen cells from donor 
mice treated 7 d earlier with NP-modified syngeneic cells were unable to suppress an 
in  vitro  response  when  added  directly  to  responder  cultures  (data  not  shown). 
Furthermore, the ability of these cells to suppress an effector-phase response suggested 
that they correspond to second order suppressor cells (Ts2 or Ts  ~) described in other 
systems (1-3, 6). 
The detection of the Lyt-2 determinant on effector-phase suppressor cells in the NP 
system  was  consistent  with  results  obtained  in  other systems  (31,  32).  Thus,  cells 
capable of effecting immune suppression in several systems were lysed by treatment 
with anti-Lyt-2 antiserum plus C but not by anti-Lyt 1 plus C  (1, 26, 33). It is unlikely 
that this Lyt-2  +, T  suppressor cell is a cytotoxic T  lymphocyte because the NP-spleen 
cell-induced, effector-phase suppressor cell described in this (data not shown) and the 
related  contact  sensitivity  system  bears  I-J  region-encoded  determinants  that  are 
thought  to  be  absent  on  cytolytic T  cells  (26).  Furthermore,  the  suppressor  cells 
described in this report fail to kill Npb-bearing hybridoma cell lines. 
Effector-phase suppression  appeared  to be NP specific because subcultured  NP- 
induced suppressor cells failed to alter the in  vitro response to SRBC,  even in the 
presence of the  NP  determinant.  Evidence provided by both  in  vivo and  in  vitro 
studies suggested that suppression occurred at the B cell level. Thus, the response to 
NP-Ficoll, a relatively T-independent antigen (17, 34), was decreased by the addition 
of NP-induced suppressor cells in vitro. In addition, the magnitude of the NP-specific 
response  to  NP-poly-(L-GIu54-L-Lysa6-L-AIa  1°)  in  vivo  was  significantly  decreased 
despite  the  presence of poly-(L-Glu~-L-Lys36-L-Alal°)-specific T  helper cell activity 
(17). 
The fine specificity of effector-phase suppression was determined by the measure- 
ment of suppression of idiotype-bearing B cell clones. For this purpose, a  guinea pig 
antiserum was raised against purified anti-NP antibodies from C57BL/6 mice. This 
reagent was able to inhibit NP-specific plaque formation only in mice of the Igh-1 b 
allotype (17). With  this reagent, it was possible to demonstrate that  effector-phase 
suppressor T  cells specifically affected the expression of idiotype-positive B cells either 
in vivo or in vitro. That is, idiotype-negative clones were not suppressed even in the 
face of active suppression of idiotype-positive cells. In fact, the suppression of NP  b- 
bearing  clones  in  vitro  appeared  in  some  experiments  to  allow  the  expression  of 
previously undetected NP  b negative B cells (Table I). This phenomenon may reflect 
the competition of NP  b idiotype-positive and -negative B cells for T  helper activity or 
antigen required for terminal differentiation and expression of PFC. The ability of 
effector-phase suppressor cells to preferentially affect the NP  b idiotype-bearing B cell 
clones may have been brought about by one of two possible mechanisms.  First, an 
antigen-bridging mechanism  may have resulted in the selective suppression of cells 
that bore high affinity receptors for the hapten. If these high affinity cells corresponded 
to  NP  b idiotype-bearing B  cells,  then these  cells would  have been selectively sup- 
pressed. Alternatively, immune suppression in the effector phase of a  response may 
have been manifested by recognition of idiotypic determinants on target cells. Because DAVID H. SHERR AND MARTIN E. DORF  1453 
effector-phase suppressor  cells  bound  idiotype-bearing antibody,  it  appeared  that 
their  interaction  with  target  cells  required  recognition  of idiotypic determinants. 
Thus,  antigen bridging did not seem  to be  involved at  least  in  the interaction of 
effector-phase suppressor cells and their immediate target lymphocytes. 
The requirement for recognition of idiotypic determinants by effector-phase sup- 
pressor cells was further substantiated by their inability to function across an  Igh 
allotype barrier.  Thus,  the  absence  of a  homologous idiotype in  Igh-mismatched 
recipients of effector-phase suppressor cells precluded recognition of target cells and 
thereby inhibited suppressor function. Similar findings have been reported in other 
systems  in  which  interaction  of T  cell  subsets  was  required  for  manifestation of 
immune suppression (4, 24-26). The ability of suppressor cells induced in C3H/HeJ 
mice to suppress the ongoing response of syngeneic responder cells in vitro suggested 
either that a relatively homogeneous suppressor population recognized a predominant 
idiotype (NP  i) common to all C3H mice or that the suppressor cell population was 
heterogeneous and recognized a series of idiotypes common only to that strain. 
Although the effector-phase suppressor  T  cell described in  this work recognized 
molecules bearing the NP  b idiotype determinant and the overall effect of the sup- 
pression was the specific inhibition of idiotype-bearing B cells, there is, to date, no 
direct evidence proving that the effector-phase suppressor cell was in fact the final 
effector cell in the suppressor pathway. Thus, it is possible that the Lyt-2  + effector- 
phase T  cell induced by subculture of spleen cells from NP-syngeneic cell-treated 
donors was merely an intermediary that interacted with and stimulated the final cell 
in  the suppressor  circuit whose direct  target  was the NP  b idiotype-bearing B  cell. 
Results obtained in other systems have suggested that  a  "T auxiliary" or Ts~ cell 
present in antigen primed populations was required for effector-phase (i.e., idiotype- 
specific) T  suppressor cells to express their suppressive function (26, 35). Experiments 
designed to elucidate this suppressor pathway further are currently underway. 
In this report we have described a system in which idiotype-specific, effector-phase 
suppressor T  cells were induced with antigen-modified syngeneic spleen cells.  This 
study departed in that regard from other investigations in which idiotype-reactive T 
cells were generated by injection of idiotypic or anti-idiotypic antibodies (10,  11, 15, 
18-20).  Although  induction  of T  cell  suppressor  circuits with  these  antibodies  is 
possible, induction of regulatory T cells with antigen probably reflects the physiologic 
role of these cells more accurately. The study of such a hapten-induced suppressor cell 
circuit will help clarify the nature of cellular interactions required to regulate the 
immune response to foreign antigens or to self antigens presented in the context of self 
cell surface determinants. It is important to emphasize that the effector-phase sup- 
pressor cells described in the present report have the same properties (idiotype binding, 
effector phase, Igh restricted, Lyt-2 bearing) as the effector-phase suppressor T  cells, 
which suppress DTH and contact sensitivity responses  (6, 24,  26).  Thus, it appears 
that the same suppressor cell populations are able to regulate both T  cell and B cell 
responses. 
Summary 
The ability of T suppressor cells, induced by the intravenous injection of 4-hydroxy- 
3-nitrophenyl acetyl (NP)-modified syngeneic spleen cells, to affect an ongoing B cell 
response was studied in vitro. It was found that the expression of NP  u idiotype-positive 1454  EFFECTOR-PHASE  SUPPRESSION  OF PLAQUE-FORMING CELLS 
B  cells could be selectively inhibited  by the addition  of antigen-induced  suppressor 
cells in the last  24 h  of the in vitro culture.  This effector-phase suppression  of B cell 
responses was antigen specific and mediated by an Lyt 1-, Lyt 2 +, idiotype-binding, 
T  cell population whose suppressive function was restricted by genes linked to the Igh 
lOCUS. 
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